Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1994;24:653-662

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bohm, M.
Right arrow Articles by Erdmann, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bohm, M.
Right arrow Articles by Erdmann, E.

Hypertension, Vol 24, 653-662, Copyright © 1994 by American Heart Association


ARTICLES

Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats

M Bohm, M Moll, B Schmid, M Paul, D Ganten, M Castellano and E Erdmann
Klinik III fur Innere Medizin, Universitat zu Koln, Germany.

We studied neuroeffector defects in hypertrophied myocardium of hypertensive transgenic rats harboring the mouse Ren-2d gene. In transgenic rats, epinephrine and neuropeptide Y concentrations were reduced. A heterologous desensitization of adenylyl cyclase was observed, which was accompanied by a downregulation of beta 1- adrenergic receptors, an increase of inhibitory G protein alpha- subunits, and a mildly depressed catalyst activity of adenylyl cyclase, whereas the bioactivity of stimulatory G protein alpha-subunits and beta 2-adrenergic receptors was unchanged. Desensitization of adenylyl cyclase was accompanied by a reduced positive inotropic response to isoproterenol, whereas the effect of Ca2+ was unchanged. We conclude that sympathetic neuroeffector defects occur in transgenic rats similar to those observed in human failing myocardium. These alterations occur in the stage of hypertrophy and could contribute to contractile dysfunction in later stages.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Kitagawa, D. Yamashita, H. Ito, and M. Takaki
Reversible effects of isoproterenol-induced hypertrophy on in situ left ventricular function in rat hearts
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H277 - H285.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Nagata, C. Communal, C. C. Lim, M. Jain, T. M. Suter, F. R. Eberli, N. Satoh, W. S. Colucci, C. S. Apstein, and R. Liao
Altered beta -adrenergic signal transduction in nonfailing hypertrophied myocytes from Dahl salt-sensitive rats
Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2502 - H2508.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
U. Schotten, K. Filzmaier, B. Borghardt, S. Kulka, F. Schoendube, C. Schumacher, and P. Hanrath
Changes of beta -adrenergic signaling in compensated human cardiac hypertrophy depend on the underlying disease
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2076 - H2083.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Dzimiri
Regulation of beta -Adrenoceptor Signaling in Cardiac Function and Disease
Pharmacol. Rev., September 1, 1999; 51(3): 465 - 502.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Iaccarino, P. C. Dolber, R. J. Lefkowitz, and W. J. Koch
ß-Adrenergic Receptor Kinase-1 Levels in Catecholamine-Induced Myocardial Hypertrophy : Regulation by ß- but not {alpha}1-Adrenergic Stimulation
Hypertension, January 1, 1999; 33(1): 396 - 401.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Bohm, M. Castellano, M. Flesch, C. Maack, M. Moll, M. Paul, F. Schiffer, and O. Zolk
Chamber-Specific Alterations of Norepinephrine Uptake Sites in Cardiac Hypertrophy
Hypertension, November 1, 1998; 32(5): 831 - 837.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Bohm, S. Ettelbruck, M. Flesch, W. H van Gilst, A. Knorr, C. Maack, Y. M Pinto, M. Paul, A. C.H Teisman, and O. Zolk
{beta}-Adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy
Cardiovasc Res, October 1, 1998; 40(1): 146 - 155.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. Zolk, M. Flesch, G. Nickenig, P. Schnabel, and M. Bohm
Alteration of intracellular Ca2+-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats
Cardiovasc Res, July 1, 1998; 39(1): 242 - 256.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Sitzler, O. Zolk, U. Laufs, M. Paul, and M. Bohm
Vascular ß-Adrenergic Receptor Adenylyl Cyclase System From Renin-Transgenic Hypertensive Rats
Hypertension, May 1, 1998; 31(5): 1157 - 1165.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Bohm, O. Zolk, M. Flesch, F. Schiffer, P. Schnabel, J.-P. Stasch, and A. Knorr
Effects of Angiotensin II Type 1 Receptor Blockade and Angiotensin-Converting Enzyme Inhibition on Cardiac ß-Adrenergic Signal Transduction
Hypertension, March 1, 1998; 31(3): 747 - 754.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Schnabel, T. Nohr, G. Nickenig, M. Paul, and M. Bohm
{alpha}-Adrenergic Signal Transduction in Renin Transgenic Rats
Hypertension, December 1, 1997; 30(6): 1356 - 1361.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Flesch, F. Schiffer, O. Zolk, Y. Pinto, S. Rosenkranz, C. Hirth-Dietrich, G. Arnold, M. Paul, and M. Bohm
Contractile Systolic and Diastolic Dysfunction in Renin-Induced Hypertensive Cardiomyopathy
Hypertension, September 1, 1997; 30(3): 383 - 391.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D.-J. Choi, W. J. Koch, J. J. Hunter, and H. A. Rockman
Mechanism of beta -Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased beta -Adrenergic Receptor Kinase
J. Biol. Chem., July 4, 1997; 272(27): 17223 - 17229.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Castellano and M. Bohm
The Cardiac ß-Adrenoceptor–Mediated Signaling Pathway and Its Alterations in Hypertensive Heart Disease
Hypertension, March 1, 1997; 29(3): 715 - 722.
[Abstract] [Full Text]


Home page
CirculationHome page
M. Bohm, M. Castellano, E. Agabiti-Rosei, M. Flesch, M. Paul, and E. Erdmann
Dose-Dependent Dissociation of ACE-Inhibitor Effects on Blood Pressure, Cardiac Hypertrophy, and ß-Adrenergic Signal Transduction
Circulation, November 15, 1995; 92(10): 3006 - 3013.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
C. L. Antos, N. Frey, S. O. Marx, S. Reiken, M. Gaburjakova, J. A. Richardson, A. R. Marks, and E. N. Olson
Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A
Circ. Res., November 23, 2001; 89(11): 997 - 1004.
[Abstract] [Full Text] [PDF]